Jim Wang | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Jim Wang is active.

Explore More

Publication

Featured researches published by Jim Wang.

Blood | 2009

Update On Imatinib-Resistant Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP) On Nilotinib Therapy at 24 Months: Clinical Response, Safety, and Long-Term Outcomes.

Hagop M. Kantarjian; Francis J. Giles; Kapil N. Bhalla; Javier Pinilla-Ibarz; Richard A. Larson; Norbert Gattermann; Oliver G. Ottmann; Andreas Hochhaus; Jerald P. Radich; Giuseppe Saglio; Timothy P. Hughes; Giovanni Martinelli; Dong-Wook Kim; Yaping Shou; Neil Gallagher; Jim Wang; Jorge Cortes-Franco; Michele Baccarani; Philipp le Coutre

Blood | 2009

Impact of Prior Therapy and Suboptimal Response to Imatinib On the Efficacy and Safety of Nilotinib Among 1,422 Patients with Imatinib-Resistant or —Intolerant Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): Sub-Analyses of the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.

Franck E. Nicolini; Dong-Wook Kim; B. Ceglarek; Anna G. Turkina; Giuliana Alimena; Haifa Kathrin Al-Ali; Zhixiang Shen; Graeme N. Smith; Carmino Antonio de Souza; Pedro Enrique Dorlhiac-Llacer; David A. Rizzieri; Tomasz Szczudlo; Myriam Berton; Jim Wang; Christine Bieri; Philipp le Coutre

Blood | 2009

Efficacy and Safety of Nilotinib in Elderly Patients with Imatinib-Resistant or -;Intolerant Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): A Sub-Analysis of the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.

Philipp le Coutre; Anna G. Turkina; Dong-Wook Kim; B. Ceglarek; Giuliana Alimena; Haifa Kathrin Al-Ali; Zhixiang Shen; Graeme N. Smith; Carmino Antonio de Souza; Pedro Enrique Dorlhiac-Llacer; David A. Rizzieri; Tomasz Szczudlo; Myriam Berton; Jim Wang; Si-Tien Wang; Franck E. Nicolini

Blood | 2009

Prognostic Factors for Progression-Free Survival in Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Nilotinib Based On 24 Month Data.

Hagop M. Kantarjian; Elias Jabbour; Francis J. Giles; Kapil N. Bhalla; Javier Pinilla-Ibarz; Richard A. Larson; Norbert Gattermann; Oliver G. Ottmann; Jim Wang; Richard C. Woodman; Michele Baccarani; Philipp le Coutre; Jorge Cortes

Blood | 2009

Patterns and Management of Selected Adverse Events of Adult Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) From the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.

Philipp le Coutre; B. Ceglarek; Anna G. Turkina; Dong-Wook Kim; Giuliana Alimena; Haifa Kathrin Al-Ali; Zhixiang Shen; Graeme N. Smith; Carmino Antonio de Souza; David A. Rizzieri; Tomasz Szczudlo; Myriam Berton; Jim Wang; Ellison Dial; Franck E. Nicolini

Journal of Clinical Oncology | 2017

Effect of abiraterone acetate and low-dose prednisone on PSA in patients with nonmetastatic castration-resistant prostate cancer: The results from IMAAGEN core study.

Charles J. Ryan; E. David Crawford; Neal D. Shore; Willie Underwood; Jim Wang; Jannell DePalantino; Anil Londhe; Zandong Yang; Tracy McGowan; Philip W. Kantoff

Blood | 2006

A Randomized Single−Blind Study of Extracorporeal Photopheresis with UVADEX® Plus Conventional Therapy (CT) Compared to CT Alone in Chronic GVHD.

Mary E.D. Flowers; Koen van Besien; Jane F. Apperley; Andrea Bacigalupo; Ahmet H. Elmaagacli; Andrew Grigg; Hans-Jochem Kolb; Luis Fernando Bouzas; Mauricette Michallet; Vijay Reddy; Jim Wang; Paul Williamson; Robert Knobler; Hildegard Greinix

Blood | 2009

Molecular Response, Efficacy and Safety Analysis of 168 Adult French Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) From the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.

Franck E. Nicolini; Gabriel Etienne; Dominique Bordessoule; Denis Caillot; Coralie Belanger; Jean-Michel Cayuela; Aude Charbonnier; Valérie Coiteux; Agnès Guerci-Bresler; Viviane Dubruille; Thierry Lamy; Françoise Huguet; Philippe Rousselot; Michel Tulliez; Jean-Yves Cahn; Martine Gardembas-Pain; Laurence Legros; Frédéric Maloisel; Delphine Rea; Hyacinthe Johnson-Ansah; Pascal Lenain; Alain Delmer; Marc Berger; Tomasz Szczudlo; Jim Wang; Mei Sheng Duh; François Guilhot

The Journal of Urology | 2015

MP87-19 EFFECT OF ABIRATERONE ACETATE AND LOW DOSE PREDNISONE ON PROSTATE-SPECIFIC ANTIGEN IN PATIENTS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: THE RESULTS FROM IMPACT OF ABIRATERONE ACETATE IN PROSTATE-SPECIFIC ANTIGEN CORE STUDY

Charles J. Ryan; E. David Crawford; Neal D. Shore; Willie Underwood; Jim Wang; Jannell DePalantino; Anil Londhe; Zane Yang; Shawn Black; Tracy McGowan; Philip W. Kantoff

The Journal of Urology | 2015

MP73-12 UNSUSPECTED METASTASES FOUND DURING SCREENING FOR A TRIAL OF PATIENTS WITH NON-METASTATIC CASTRATION RESISTANT PROSTATE CANCER

E. David Crawford; Jannell DePalantino; Philip W. Kantoff; Neal D. Shore; Willie Underwood; Vijay Reddy; Jim Wang; Suneel Mundle; Zane Yang; Tracy McGowan; Charles J. Ryan

Explore More